Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2012 Q1- Text added to 2012 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
affiliate, BioPharmaceutical, bond, call, Chatham, dialogue, EFSF, Fasonut, filler, FlowsCondensed, French, gene, IncomeCondensed, individually, Laboratoire, milestone, parenteral, penetration, refined, rehearing, rejection, SheetsCondensed, shutdown, void
Removed:
AWP, behalf, consented, designed, determine, dismissal, dozen, eligible, endoscopy, executing, health, IGIV, improperly, incremental, indemnity, inflated, introduced, large, Las, manipulated, manufactured, manufacturer, Medicaid, Medicare, Nevada, nineteen, offering, originated, penalty, permit, prepaid, propofol, qui, receive, recourse, reentry, refund, replace, resolved, reused, seek, service, Servicing, sought, Spectrum, tam, terminate, Teva, transmission, trial, unused, USA, weakening, wholesale
Valuein 2012 Q1 filing- Value in 2012 Q2 filing
Original filings
Filing view